{
    "clinical_study": {
        "@rank": "85534", 
        "arm_group": [
            {
                "arm_group_label": "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                "arm_group_type": "Experimental", 
                "description": "Lotrafilcon B contact lenses with OPTI-FREE PUREMOIST for 30 days, followed by BIOTRUE for an additional 30 days.  A fresh pair of lenses was dispensed for each solution."
            }, 
            {
                "arm_group_label": "Lotrafilcon B with Biotrue, then Opti-Free Puremoist", 
                "arm_group_type": "Experimental", 
                "description": "Lotrafilcon B contact lenses with BIOTRUE for 30 days, followed by OPTI-FREE PUREMOIST for an additional 30 days.  A fresh pair of lenses was dispensed for each solution."
            }, 
            {
                "arm_group_label": "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                "arm_group_type": "Active Comparator", 
                "description": "Senofilcon A contact lenses with OPTI-FREE PUREMOIST for 30 days, followed by BIOTRUE for an additional 30 days.  A fresh pair of lenses will be dispensed for each solution, with biweekly replacement."
            }, 
            {
                "arm_group_label": "Senofilcon A with Biotrue, then Opti-Free Puremoist", 
                "arm_group_type": "Active Comparator", 
                "description": "Senofilcon A with BIOTRUE for 30 days, followed by OPTI-FREE PUREMOIST for an additional 30 days.  A fresh pair of lenses will be dispensed for each solution, with biweekly replacement."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the lipid uptake, wetting characteristics, and\n      visual performance of AIR OPTIX\u00ae AQUA and ACUVUE\u00ae OASYS\u00ae with HYDRACLEAR\u00ae contact lenses\n      when used in conjunction with two contact lens care systems, OPTI-FREE\u00ae PUREMOIST\u00ae MPDS and\n      BIOTRUE\u00ae."
        }, 
        "brief_title": "Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Myopia", 
            "Astigmatism", 
            "Refractive Error"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Astigmatism", 
                "Myopia", 
                "Refractive Errors"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will be divided into two phases, a pre-investigational screening phase and an\n      investigational phase. During the pre-investigational screening phase, all participants will\n      use PureVision contact lenses and ReNu Multiplus multipurpose solution per manufacturers'\n      guidelines for 30 days. Eligible participants will continue into the investigational phase\n      and will be randomly assigned to wear Air Optix Aqua or Oasys lenses with two months\n      randomized crossover of contact lens care (one month each of Opti-Free PureMoist MPDS and\n      Biotrue MPS)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Read and understand the Participant Information Sheet;\n\n          -  Read, sign, and date the Informed Consent;\n\n          -  Be a current silicone hydrogel contact lens wearer using the contact lenses under a\n             frequent replacement (bi-weekly or monthly) daily wear modality;\n\n          -  Be classified as symptomatic and a depositor at the end of the replacement period\n             according to protocol-specified criteria;\n\n          -  Agree to wear study contact lenses as directed for the duration of the study and\n             maintain the appointment schedule;\n\n          -  Best corrected visual acuity of 6/9 or better in each eye;\n\n          -  Normal eyes with the exception of the need for visual correction;\n\n          -  Other protocol-defined inclusion criteria may apply.\n\n        Exclusion Criteria:\n\n          -  Known sensitivity or intolerance to any of the contact lenses or contact lens care\n             products to be used;\n\n          -  Monocular vision (only one eye with functional vision or only one eye fitted with\n             contact lenses);\n\n          -  Use of systemic medication which might interfere with contact lens wear or produce\n             dry eye side effects;\n\n          -  Systemic disease which might interfere with contact lens wear or produce dry eye side\n             effects;\n\n          -  Systemic or ocular allergies which might interfere with contact lens wear;\n\n          -  Ocular disease which might interfere with contact lens wear;\n\n          -  Active ocular infection;\n\n          -  Use of any concomitant topical ocular medications during the study period;\n\n          -  Previous ocular surgery;\n\n          -  Pregnant, planning to become pregnant, or lactating at the time of enrollment;\n\n          -  Participation in an investigational drug or device study within 30 days of entering\n             this study;\n\n          -  Other protocol-defined exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "109", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699750", 
            "org_study_id": "M-12-043 / ID11-59"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                    "Lotrafilcon B with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Silicone hydrogel contact lenses worn on a daily wear basis and used with OPTI-FREE PUREMOIST or BIOTRUE lens care systems, 30 days each system, during Phase Two (Investigational Phase)", 
                "intervention_name": "Lotrafilcon B contact lenses (AIR OPTIX AQUA)", 
                "intervention_type": "Device", 
                "other_name": "AIR OPTIX\u00ae AQUA"
            }, 
            {
                "arm_group_label": [
                    "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                    "Senofilcon A with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Silicone hydrogel contact lenses worn on a daily wear basis and used with OPTI-FREE PUREMOIST or BIOTRUE lens care systems, 30 days each system, during Phase Two (Investigational Phase).  Contact lenses replaced biweekly.", 
                "intervention_name": "Senofilcon A contact lenses (ACUVUE OASYS with HYDRACLEAR)", 
                "intervention_type": "Device", 
                "other_name": "ACUVUE\u00ae OASYS\u00ae with HYDRACLEAR\u00ae"
            }, 
            {
                "arm_group_label": [
                    "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                    "Lotrafilcon B with Biotrue, then Opti-Free Puremoist", 
                    "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                    "Senofilcon A with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Contact lens care system used with AIR OPTIX AQUA and ACUVUE OASYS WITH HYDRACLEAR contact lenses, 30 days each, during Phase Two (Investigational Phase)", 
                "intervention_name": "OPTI-FREE PUREMOIST Multipurpose Disinfecting System (MPDS) contact lens care system", 
                "intervention_type": "Device", 
                "other_name": "OPTI-FREE\u00ae PUREMOIST\u00ae MPDS"
            }, 
            {
                "arm_group_label": [
                    "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                    "Lotrafilcon B with Biotrue, then Opti-Free Puremoist", 
                    "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                    "Senofilcon A with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Contact lens care system used with AIR OPTIX AQUA and ACUVUE OASYS WITH HYDRACLEAR contact lenses, 30 days each, during Phase Two (Investigational Phase)", 
                "intervention_name": "BIOTRUE contact lens care system", 
                "intervention_type": "Device", 
                "other_name": "BIOTRUE\u00ae"
            }, 
            {
                "arm_group_label": [
                    "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                    "Lotrafilcon B with Biotrue, then Opti-Free Puremoist", 
                    "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                    "Senofilcon A with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Silicone hydrogel contact lenses worn on a daily wear basis for 30 days during Phase One (Pre-Investigational Phase).", 
                "intervention_name": "Balafilcon A contact lenses (PureVision)", 
                "intervention_type": "Device", 
                "other_name": "PureVision"
            }, 
            {
                "arm_group_label": [
                    "Lotrafilcon B with Opti-Free Puremoist, then Biotrue", 
                    "Lotrafilcon B with Biotrue, then Opti-Free Puremoist", 
                    "Senofilcon A with Opti-Free Puremoist, then Biotrue", 
                    "Senofilcon A with Biotrue, then Opti-Free Puremoist"
                ], 
                "description": "Contact lens care system used for 30 days during Phase One (Pre-Investigational Phase)", 
                "intervention_name": "ReNu Multiplus contact lens care system", 
                "intervention_type": "Device", 
                "other_name": "ReNu Multiplus"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Contact Lens Solutions"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "contact lenses", 
            "contact lens solution", 
            "myopia", 
            "astigmatism"
        ], 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Worth", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "76134"
                }, 
                "name": "Contact Alcon Call Center at 1-888-451-3937 for Trial Locations"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems", 
        "overall_official": {
            "affiliation": "Alcon Research", 
            "last_name": "Jami Kern, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Ex-Vivo Lipid Uptake", 
            "safety_issue": "No", 
            "time_frame": "Day 30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699750"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Non-Invasive Tear Film Break Up Time", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Time-Controlled Visual Acuity", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Subjective Comfort", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Dryness", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }
        ], 
        "source": "Alcon Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alcon Research", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}